RT Journal Article
SR Electronic
T1 COVID-19 Mortality in Women and Men in Sub-Saharan Africa: A Cross Sectional Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.31.21261422
DO 10.1101/2021.07.31.21261422
A1 Dalal, Jyoti
A1 Triulzi, Isotta
A1 James, Ananthu
A1 Nguimbis, Benedict
A1 Dri, Gabriela Guizzo
A1 Venkatasubramanian, Akarsh
A1 Royd Lucie, Noubi Tchoupopnou
A1 Mesa, Sara Botero
A1 Somerville, Claire
A1 Turchetti, Giuseppe
A1 Stoll, Beat
A1 Abbate, Jessica Lee
A1 Mboussou, Franck
A1 Impouma, Benido
A1 Keiser, Olivia
A1 Coelho, Flávio Codeço
YR 2021
UL http://medrxiv.org/content/early/2021/08/02/2021.07.31.21261422.abstract
AB Objective To investigate differences of COVID-19 related mortality among women and men across sub-Saharan Africa (SSA) from the beginning of the pandemic.Design A cross sectional study.Setting Data from 20 member nations of the WHO African region until September 1, 2020.Participants 69,580 cases of COVID-19, stratified by sex (men, n=43071; women, n=26509) and age (0-39 years, n=41682; 40-59 years, n=20757; 60+ years, n=7141).Main outcome measures We computed the SSA- and country-specific case fatality rates (CFRs) and sex-specific CFR differences across various age groups, using a Bayesian approach.Results A total of 1,656 (2.4% of total cases reported; 1656/69580) deaths were reported, with men accounting for 1168/1656 (70.5%) of total deaths. In SSA, women had a lower CFR than men (mean CFRdiff = -0.9%; 95% credible intervals -1.1% to -0.6%). The mean CFR estimates increased with age, with the sex-specific CFR differences being significant among those aged 40 or more (40-59 age-group: mean CFRdiff = -0.7%; 95% credible intervals -1.1% to -0.2%; 60+ age-group: mean CFRdiff = -3.9%; 95% credible intervals -5.3% to -2.4%). At the country level, seven of the twenty SSA countries reported significantly lower CFRs among women than men overall. Moreover, corresponding to the age-specific datasets, significantly lower CFRs in women than men were observed in the 60+ age-group in seven countries and 40-59 age-group in one country.Conclusions >Sex and age are important predictors of COVID-19 mortality. Countries should prioritize the collection and use of sex-disaggregated data to understand the evolution of the pandemic. This is essential to design public health interventions and ensure that policies promote a gender sensitive public health response.What is already known on this topicLittle is known on the impact of COVID-19 among different sexes and age-groups in sub-Saharan Africa (SSA).The availability of data on COVID-19 cases and deaths, disaggregated by both age and sex from the WHO African region has been scarce.In most of the non-African countries, sex-specific COVID-19 severity and mortality were substantially worse for men than for women, during the first wave of the novel coronavirus (COVID-19) pandemic.What this study addsTo the best of our knowledge, this is the largest study focussing on the COVID-19 related fatalities among men and women in SSA, and it confirmed that both sex and age are important predictors of COVID-19 mortality in SSA, similar to other regions.In SSA, overall, men had a higher case fatality rate (CFR) than women. When disaggregated by age, this difference persisted only in individuals aged 40 or more. 7 among the 20 SSA countries included in this study also reported significantly higher CFRs in men than women for the age-aggregated dataset.Public health prevention activities and responses should take into account gender differences in terms of disease severity and mortality, especially among men aged 40 or more in SSA.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Swiss National Science Foundation (grants no. 196270 and 163878)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical Approval: Data were collected for surveillance purposes under IHR, and no ethical approval was needed. Moreover, no clinical trials were involved in this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data (data dictionary, statistical code) that support the findings of this study are available upon reasonable request from the corresponding author. Some of the data are publicly available through situation reports produced by Ministries of Health and WHO/AFRO on their respective websites.